EPO Patents = 1

Forward Citations = 24

Loading Chart...

5 inventors (with patents filed for the assignee):

Kiyotaka Nakano (2 out of 12 patents)

Hiroyuki Aburatani (2 out of 27 patents)

Shunpei Ishikawa (2 out of 3 patents)

4. Shigeto Kawai (1 out of 13 patents)

5. Naoki Kimura (1 out of 86 patents)

4 patents: Sort by Forward Citations

1. 9139647 - Diagnosis and treatment of cancer using anti-TM4SF20 antibody (2015-09-22),

2. 9079957 - Diagnosis and treatment of cancer using anti-TMPRSS11E antibody (2015-07-14),

3. 8546546 - Anti-Muc 17 antibody (2013-10-01),

4. 8192740 - Pharmaceutical composition comprising anti-GRP78 antibody as active ingredient (2012-06-05),

Company Overview

Forerunner Pharma Research Co., Ltd. is a leading research and development company focused on innovative pharmaceutical solutions. With a strong commitment to improving global health, we specialize in drug discovery, preclinical and clinical development, and manufacturing services. Our team of experienced scientists and researchers are dedicated to advancing the field of medicine through cutting-edge technologies and collaborations with leading academic institutions. Visit our website to learn more about our latest projects and partnerships.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#3,053 in Tokyo

#7,579 in Japan

Tokyo, Japan

Forerunner Pharma Research Co., Ltd.

Forward Citations = 24

5 inventors:

Kiyotaka Nakano (2 out of 12 patents)

Hiroyuki Aburatani (2 out of 27 patents)

Shunpei Ishikawa (2 out of 3 patents)

4. Shigeto Kawai (1 out of 13 patents)

5. Naoki Kimura (1 out of 86 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Forerunner Pharma Research Co., Ltd.. Retrieved from https://idiyas.com/company/forerunner-pharma-research-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]